Tivozanib Promising for Metastatic Renal Cell Carcinoma

Updated clinical trial results reveal Tivozanib superior to Nexavar and headed to the FDA for US approval.12/13/2018
Source: Kidney Cancer Association - Category: Urology & Nephrology Source Type: news